The term "PER20" could represent a typographical error or misinterpretation of established antibody nomenclature. Two plausible candidates emerge from the search results:
PER2 (Period circadian protein homolog 2) is a circadian rhythm regulator studied in chronobiology. A polyclonal antibody targeting PER2 (PA5-100107) is commercially available, with applications in Western blotting and immunofluorescence .
| Parameter | PER2 Antibody (PA5-100107) |
|---|---|
| Target Protein | PER2 (UniProt ID: O15055, O54943) |
| Host Species | Rabbit |
| Applications | WB, IF, IHC |
| Reactive Species | Human, Mouse, Rat |
| Supplier | Thermo Fisher Scientific |
PY20 is a well-characterized monoclonal antibody targeting phosphotyrosine residues, widely used in signaling pathway studies .
| Parameter | PY20 Antibody |
|---|---|
| Specificity | Phosphorylated tyrosine residues |
| Host Species | Mouse (IgG2b) |
| Applications | WB, IP, Flow Cytometry, IHC |
| Conjugates Available | HRP, FITC, PE, Alexa Fluor® variants |
| Key Suppliers | Santa Cruz Biotechnology, Thermo Fisher |
Function: PER2 regulates circadian oscillations and interacts with core clock proteins like CRY1/2 and CLOCK .
Pathological Relevance: Mutations in PER2 are linked to familial advanced sleep-phase syndrome (FASPS) .
Experimental Use: Used to study circadian disruption in metabolic diseases and cancer .
Mechanism: Binds phosphorylated tyrosine residues on activated receptors (e.g., EGFR) and signaling proteins .
Applications:
Technical Data:
| Feature | PER2 Antibody | PY20 Antibody |
|---|---|---|
| Target Type | Structural protein | Post-translational modification |
| Research Focus | Circadian biology | Signal transduction, oncology |
| Commercial Availability | Limited to PER2-specific suppliers | Broadly available across vendors |
| Clinical Relevance | Genetic disorders | Cancer biomarker studies |
Terminology Verification: Confirm whether "PER20" refers to a novel antibody not yet cataloged or a typographical error.
Exploratory Targets:
Validation Protocols: If developing a novel PER20 antibody, utilize phage display libraries or single-chain variable fragment (scFv) platforms for epitope characterization.